RPFT flashcards
RPFT · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- PFT pre-test medication hold
- Short-acting bronchodilators are typically withheld 4–6 hours, long-acting beta-agonists 12–24 hours, and short-acting anticholinergics 6–8 hours before testing, per laboratory protocol.
- Height and weight measurement
- Measure standing height without shoes and record weight before testing; these variables, with age, sex, and race/ethnicity, are used to calculate predicted pulmonary function values.
- Contraindication to spirometry
- Recent myocardial infarction, unstable angina, pneumothorax, active hemoptysis, or recent thoracic or abdominal surgery are contraindications because forced maneuvers increase intrathoracic pressure and cardiovascular demand.
- Nose clip during spirometry
- A nose clip prevents air leakage through the nose during forced expiratory and inspiratory maneuvers, improving measurement accuracy and reproducibility of flows and volumes.
- Rest before PFT
- Avoid vigorous exercise for at least 30 minutes and smoking for at least 1 hour before testing, because these can alter airway caliber and test results.
- Documenting bronchodilator use
- Record the name, dose, and time of any bronchodilator taken before testing so results can be interpreted in light of recent medication exposure.
- Predicted values inputs
- Age, height, sex, and race/ethnicity are entered into reference equations to generate predicted values and lower limits of normal for pulmonary function tests.
- Daily spirometer calibration check
- Before each testing day, check spirometer volume with a calibrated 3-L syringe; measured volume should be within ±3.5% of the syringe volume, and log the result.
- BTPS correction
- Spirometry volumes are reported at body temperature, ambient pressure, saturated with water vapor; converting from ATPS to BTPS corrects for temperature, pressure, and humidity differences.
- DLCO gas analyzer calibration
- Calibrate carbon monoxide and tracer gas analyzers daily using zero and span gases; verify linearity and record results before patient testing.
- Plethysmograph calibration
- Calibrate the plethysmograph pressure transducers and box volume daily, verifying known volume and pressure signals before measuring lung volumes.
- Leak test
- Perform a daily leak test on spirometers and plethysmographs; a leak can falsely reduce measured volumes and flows and invalidate test results.
- Biological control subject
- A healthy staff member may be tested periodically as a biological control; results should remain within established limits, helping detect system drift not found by syringe checks.
- Calibration log requirements
- Record date, device, calibrator identity, expected and measured values, and corrective action; retain logs according to laboratory policy and regulatory requirements.
- Acceptable spirometry trial
- An acceptable FVC trial has a rapid start, no cough in the first second, no glottic closure or leak, and a complete exhalation without early termination.
- Reproducibility criterion
- The two largest FVC values and the two largest FEV1 values should agree within 150 mL; perform up to three acceptable trials, and more if needed.
- Back-extrapolated volume
- Back-extrapolated volume should be less than 5% of FVC or 150 mL, whichever is greater, indicating a satisfactory rapid start to the forced expiration.
- End-of-test plateau
- A plateau is present when the volume change is less than 25 mL during the final second; otherwise continue until at least 6 seconds and up to 15 seconds.
- Bronchodilator response testing
- Repeat spirometry 10–15 minutes after a short-acting beta-agonist; a significant response is an increase in FEV1 or FVC of at least 12% and 200 mL.
- Single-breath DLCO maneuver
- From residual volume, inhale the test gas rapidly to total lung capacity, hold the breath about 10 seconds, then exhale smoothly; discard the dead-space washout.
- Plethysmography panting
- With the shutter closed, the subject pants at about 1 Hz against the occluded mouthpiece while box pressure changes are recorded to calculate thoracic gas volume.
- Obstructive pattern
- Obstruction is identified by a reduced FEV1/FVC ratio below the lower limit of normal, or below 0.70 when the fixed criterion is used.
- Restrictive pattern
- Restriction is suggested by reduced FVC with a normal or high FEV1/FVC ratio and is confirmed by total lung capacity below the lower limit of normal.
- Mixed pattern
- A mixed defect shows both a reduced FEV1/FVC ratio and a reduced total lung capacity, indicating obstructive and restrictive physiology together.
- DLCO interpretation
- A low DLCO suggests emphysema, interstitial lung disease, pulmonary vascular disease, or anemia; an elevated DLCO may occur with polycythemia or pulmonary hemorrhage.
- Lower limit of normal
- The lower limit of normal is typically the fifth percentile of the reference population; values below it are considered abnormal rather than using a fixed percent predicted cutoff.
- GOLD severity
- In COPD, FEV1 percent predicted defines mild (>70%), moderate (60–69%), moderately severe (50–59%), severe (35–49%), and very severe (<35%) airflow limitation.
- Hand hygiene before PFT
- Perform hand hygiene before and after patient contact and after handling mouthpieces or filters; gloves are worn when contact with respiratory secretions is anticipated.
- Single-use mouthpieces
- Use disposable mouthpieces and bacterial/viral filters for each patient; never reuse them, and discard into appropriate waste containers after testing.
- Disinfection of reusable equipment
- Clean and disinfect reusable spirometry and plethysmography components according to manufacturer instructions, ensuring adequate contact time and thorough drying before reuse.
- Tuberculosis precautions
- For patients with suspected tuberculosis, use a bacterial/viral filter, schedule testing in a separate room, and follow airborne infection isolation and local public health guidance.
- Oxygen safety during testing
- Keep oxygen cylinders secured and away from heat or open flames; avoid smoking in testing areas because oxygen-enriched environments increase fire risk.